Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP327000.RAkk6roLbqGsbfPFmFihi1japEmjv_eAb43tXJaBteeSM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP327000.RAkk6roLbqGsbfPFmFihi1japEmjv_eAb43tXJaBteeSM130_assertion type Assertion NP327000.RAkk6roLbqGsbfPFmFihi1japEmjv_eAb43tXJaBteeSM130_head.
- NP327000.RAkk6roLbqGsbfPFmFihi1japEmjv_eAb43tXJaBteeSM130_assertion description "[The epidermal growth factor receptor (EGFR) is a tyrosine kinase (TK) involved in the tumour progression of many cancer types and may serve as an important therapeutic target (erlotinib, cetuximab).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP327000.RAkk6roLbqGsbfPFmFihi1japEmjv_eAb43tXJaBteeSM130_provenance.
- NP327000.RAkk6roLbqGsbfPFmFihi1japEmjv_eAb43tXJaBteeSM130_assertion evidence source_evidence_literature NP327000.RAkk6roLbqGsbfPFmFihi1japEmjv_eAb43tXJaBteeSM130_provenance.
- NP327000.RAkk6roLbqGsbfPFmFihi1japEmjv_eAb43tXJaBteeSM130_assertion SIO_000772 20840671 NP327000.RAkk6roLbqGsbfPFmFihi1japEmjv_eAb43tXJaBteeSM130_provenance.
- NP327000.RAkk6roLbqGsbfPFmFihi1japEmjv_eAb43tXJaBteeSM130_assertion wasDerivedFrom befree-20140225 NP327000.RAkk6roLbqGsbfPFmFihi1japEmjv_eAb43tXJaBteeSM130_provenance.
- NP327000.RAkk6roLbqGsbfPFmFihi1japEmjv_eAb43tXJaBteeSM130_assertion wasGeneratedBy ECO_0000203 NP327000.RAkk6roLbqGsbfPFmFihi1japEmjv_eAb43tXJaBteeSM130_provenance.